Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Oct 19, 2022

BUY
$67.99 - $89.57 $168,003 - $221,327
2,471 Added 51.89%
7,233 $550,000
Q1 2022

Apr 19, 2022

SELL
$60.15 - $84.52 $3,007 - $4,226
-50 Reduced 1.04%
4,762 $395,000
Q3 2021

Oct 15, 2021

SELL
$116.17 - $194.55 $3,833 - $6,420
-33 Reduced 0.68%
4,812 $559,000
Q2 2021

Jul 19, 2021

BUY
$130.4 - $225.58 $391 - $676
3 Added 0.06%
4,845 $1.07 Million
Q1 2021

May 07, 2021

BUY
$124.11 - $190.17 $4,964 - $7,606
40 Added 0.83%
4,842 $640,000
Q4 2020

Feb 02, 2021

BUY
$112.16 - $174.14 $538,592 - $836,220
4,802 New
4,802 $830,000

Others Institutions Holding NVCR

About NovoCure Ltd


  • Ticker NVCR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 104,950,000
  • Market Cap $1.86B
  • Description
  • NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...
More about NVCR
Track This Portfolio

Track Sumitomo Mitsui Ds Asset Management Company, LTD Portfolio

Follow Sumitomo Mitsui Ds Asset Management Company, LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sumitomo Mitsui Ds Asset Management Company, LTD, based on Form 13F filings with the SEC.

News

Stay updated on Sumitomo Mitsui Ds Asset Management Company, LTD with notifications on news.